Baker, Amanda F.
6 papers on CoChatORCID 0000-0002-0670-5381
Most cited papers
- Verified
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination
Ramanathan, R. K., Abbruzzese, J., Dragovich, T., Kirkpatrick, L., Guillen, J. M., Baker, A. F., Pestano, L. A., Green, S., & Von Hoff, D. D. (2011) · Cancer Chemotherapy and Pharmacology
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 122
- Verified
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules
Liu, Q., Sun, J. D., Wang, J., Ahluwalia, D., Baker, A. F., Cranmer, L. D., Ferraro, D., Wang, Y., Duan, J.-X., Ammons, W. S., et al. (2012) · Cancer Chemotherapy and Pharmacology
Cancer, Hypoxia, and MetabolismBioactive Compounds and Antitumor Agents
Cited by 113
- Verified
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma
Baker, A. F., Dragovich, T., Tate, W. R., Ramanathan, R. K., Roe, D., Hsu, C.-H., Kirkpatrick, D. L., & Powis, G. (2006) · Journal of Laboratory and Clinical Medicine
Redox biology and oxidative stressGlutathione Transferases and Polymorphisms
Cited by 90
- Verified
IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines
Block, K. M., Hanke, N. T., Maine, E. A., & Baker, A. F. (2012) · Pancreas
Cytokine Signaling Pathways and InteractionsPancreatic and Hepatic Oncology Research
Cited by 62
- Verified
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers
Baker, A. F., Adab, K. N., Raghunand, N., Chow, H. H. S., Stratton, S. P., Squire, S. W., Boice, M., Pestano, L. A., Kirkpatrick, D. L., & Dragovich, T. (2013) · Investigational New Drugs
Redox biology and oxidative stressGastric Cancer Management and Outcomes
Cited by 52
- Verified
Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase
Kim, Y. H., Coon, A., Baker, A. F., & Powis, G. (2011) · Cancer Chemotherapy and Pharmacology
Cancer, Hypoxia, and MetabolismRedox biology and oxidative stress
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free